A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial
Clinical trial NCT03183622 · COMPLETED
Trial details
- NCT number
- NCT03183622
- Sponsor
- Anterogen Co., Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-11-01
- Primary completion
- 2017-07-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.